Showing results (91-100 of 541) with videos related to
Sort By:
Pageof 55
Current Opinion in HIV and AIDS|December 19, 2025
Hepatitis B virus functional cure in persons with HIV: what are the predictors and which novel markers are useful?Lorin Begré, Fabien Zoulim, Anders BoydViruses|January 21, 2023
Heparanase-1: From Cancer Biology to a Future Antiviral TargetNadjet Lebsir, Fabien Zoulim, Boyan GrigorovExpert Review of Molecular Diagnostics|September 27, 2003
Early detection of hepatitis B drug resistance: implications for patient managementErwin Sablon, Fred Shapiro, Fabien ZoulimJournal of Hepatology|December 11, 2024
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis deltaElisabetta Degasperi, Caroline Scholtes, Barbara Testoni, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2012
Response-guided and -unguided treatment of chronic hepatitis CK Rajender Reddy, Frederick Lin, Fabien ZoulimThe Journal of Antimicrobial Chemotherapy|April 29, 2008
Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?Vincent Soriano, Alan S Perelson, Fabien ZoulimJournal of Medical Virology|July 13, 2002
Viral determinants and host immune responses in the pathogenesis of HBV infectionMaria Rapicetta, Carlo Ferrari, Massimo LevreroCellular and Molecular Gastroenterology and Hepatology|June 1, 2022
HIRA Supports Hepatitis B Virus Minichromosome Establishment and Transcriptional Activity in Infected HepatocytesMaëlle Locatelli, Jean-Pierre Quivy, Fleur Chapus, et al.Gut|May 2, 2024
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanismArmando Andres Roca Suarez, Marie-Laure Plissonnier, Xavier Grand, et al.Hepatology (Baltimore, Md.)|April 1, 2025
Getting to HBV Cure - will new biomarkers help?Jordan J Feld, Adam J Gehring, Fabien ZoulimPageof 55